Aileron Therapeutics Inc.

NASDAQ: ALRN · Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-62.88M -15.73M -27.33M -26.16M
Depreciation & Amortization
63K 119K 169K 121K
Stock-Based Compensation
1.12M 1.19M 2.08M 2.26M
Other Working Capital
n/a -399K -90K 628K
Other Non-Cash Items
n/a -4K -208K -213K
Deferred Income Tax
-1.55M n/a n/a n/a
Change in Working Capital
n/a -5.38M 420K 242K
Operating Cash Flow
-22.29M -19.81M -24.86M -23.75M
Capital Expenditures
n/a n/a n/a -157K
Cash Acquisitions
n/a -96K n/a 66K
Purchase of Investments
n/a n/a -21.85M -73.58M
Sales Maturities Of Investments
n/a 16.25M 48.31M 37.75M
Other Investing Acitivies
n/a 42K 26.46K -35.76K
Investing Cash Flow
n/a 16.2M 26.46M -35.92M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
7.17M 15.79M n/a 74K
Financial Cash Flow
17.82M 15.79M n/a 55.66M
Net Cash Flow
-4.47M 12.12M 1.59M -4.01M
Free Cash Flow
-22.29M -19.81M -24.86M -23.91M